Chronic Pain Market, By Drug Class (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, and Others), By Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia, and Others), By Application (Musculoskeletal, Neuropathy, Oncology, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Feb 2025

Code : CMI4767

Pages :260

Formats :

Excel and PDF

Industry : Pharmaceutical

Chronic Pain Market Size and Trends

Global chronic pain market is estimated to be valued at USD 77.30 Bn in 2025 and is expected to reach USD 125.84 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 7% from 2025 to 2032. Increasing geriatric population who are more prone to chronic diseases and various innovations in pain management therapeutics can drive the market growth during the forecast period.

Chronic Pain Market Key Factors

To learn more about this report, Request sample copy

Increasing prevalence of chronic diseases

Rising burden of chronic diseases can drive the market growth. Longer life expectancy and evolving lifestyle trends have largely contributed to this global epidemic. Chronic diseases such as diabetes, arthritis, cardiovascular diseases, and others which were earlier seen as disorders specific to developed nations are now spreading to low- and middle-income countries at an alarming rate.

Due to unhealthy diet, physical inactivity, and tobacco use, more people are becoming susceptible to these chronic conditions at younger ages. Developing countries undergoing nutrition transition are witnessing increase in obesity levels in their populations. This has further accelerated the occurrence of diabetes, joint problems and other chronic diseases. Even though healthcare infrastructure has been improving in these regions, management of chronic diseases poses significant challenges due to limited resources and awareness.

Chronic diseases often coexist with other comorbidities compounding the severity of conditions in affected patients. Diabetic patient is likely to develop hypertension, kidney complications or cardiovascular problems, if diagnosis and treatment is delayed. Mismanagement or lack of support also raises psycho-social issues for people living with chronic pain over long periods. All these factors have contributed to chronic diseases collectively becoming one of the leading causes of morbidity in both developed and developing parts of the world.

Given their irreversible and lifelong nature, the personal and economic burden associated with chronic diseases escalate with time. As more people are diagnosed, there has been increase in need for improved diagnostic methods, safer and cost-effective drugs, rehab measures and assistive devices. Organizations working in the area of chronic disease prevention have strived to raise awareness and initiate campaigns for behavioral change. However, pharmacological interventions remain critical for effective management of existing cases and alleviation of chronic pain symptoms.